Disease Imaging and Therapy Lab
Using Biomolecules, Ranging Rrom Small Molecules to Full-Length Antibodies, as Tumor-Targeting Agents to Deliver Imaging or Cytotoxic Cargo
A primary research focus of our laboratory is the conjugation, labeling, and validation of tumor-targeting molecular imaging and therapeutic agents..
Using Multimodal Imaging to Monitor the Binding of Molecular-Targeted Compounds to Tumors Before and During Therapy
To visualize a particular biological process, we take advantage of the high sensitives of PET, SPECT, or optical imaging. We use noninvasive molecular imaging to determine the role of receptor membrane dynamics and tumor stroma in cancer therapy.
Using Acute and Temporal Pharmacologic Approaches to Modulate Tumor Biology to Enhance Antibody and Non-Antibody Based Cancer Therapies
We use pharmacologic approaches with appropriate PK/PD as potential adjuvants for specific antibody-targeted and non-antibody-based cancer therapies.
Combining Basic Tumor Biology with Preclinical Knowledge and Clinical Needs to Improve Cancer Diagnosis and Treatment
Our lab uses fresh cultures of tumors and patient-derived xenografts (PDXs) to correlate antibody targeting with the respective tumor’s genetic profile and identify genetic features that characterize a non-responder versus a responder tumor. The preclinical discoveries made in our laboratory are combined with retrospective and prospective studies, prioritized and pushed towards clinical translation.